Physician profile
Ramdev Konijeti
NPI 1578708715
$20,536.28
in general payments reported to CMS, 2019-2025
37 companies · $3,926 in 2025
The $3,926 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $623 · 2021: $270 · 2022: $2,670 · 2023: $82.75 · 2024: $710 · 2025: $3,926.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,366 · Honoraria: $2,275 · Education: $77.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,365.90 |
| Honoraria | $2,275.00 |
| Education | $77.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $10,272.50 | 2019-2025 | |
| Urogen Pharma, INC. | $2,491.62 | 2022-2025 | |
| Boston Scientific Corporation | $2,428.00 | 2020-2022 | |
| Intuitive Surgical, INC. | $2,272.76 | 2019-2025 | |
| Edap Technomed INC | $379.14 | 2024-2025 | |
| Janssen Biotech, INC. | $324.66 | 2019-2025 | Erleada |
| Abbvie INC. | $271.85 | 2021-2025 | |
| Astellas Pharma US INC | $198.38 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $182.53 | 2019-2025 | Keytruda, Welireg |
| Progenics Pharmaceuticals, INC. | $173.85 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $130.52 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $127.26 | 2019-2020 | |
| Medtronic USA, INC. | $121.00 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.27 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $99.85 | 2019-2025 | Adstiladrin |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $87.29 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $75.55 | 2021-2023 | Prolaris |
| Novartis Pharmaceuticals Corporation | $72.53 | 2024-2025 | |
| Blue Earth Diagnostics | $72.47 | 2019-2020 | |
| Amgen INC. | $72.27 | 2019-2020 | |
| Teleflex LLC | $69.88 | 2019-2025 | Barrigel |
| Sumitomo Pharma America, INC. | $69.29 | 2024-2025 | Orgovyx |
| Seagen INC. | $60.72 | 2019-2020 | |
| Eisai INC. | $51.02 | 2019 | |
| Dendreon Pharmaceuticals LLC | $41.04 | 2019-2020 | |
| Histosonics, INC. | $37.12 | 2025 | |
| Emd Serono, INC. | $37.10 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $25.25 | 2020 | |
| Immunitybio, INC. | $24.77 | 2024 | |
| Antares Pharma, INC. | $22.32 | 2019 | |
| Allergan, INC. | $21.94 | 2020 | |
| 180 Medical, INC. | $19.57 | 2019 | |
| Richard Wolf Medical Instruments Corp. | $18.99 | 2019 | |
| Rochester Medical Corporation | $18.00 | 2022 | |
| Genentech USA, INC. | $17.83 | 2019 | |
| Endo Pharmaceuticals INC. | $17.78 | 2019 | |
| Sun Pharmaceutical Industries INC. | $15.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramdev Konijeti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.